Erlonat 100 MG Tablet contains Erlotinib 100mg, a dose-adjusted formulation of this EGFR inhibitor for patients requiring reduced doses due to toxicity or as part of dose modification protocols.

How It Works: Erlotinib blocks EGFR tyrosine kinase activity by competing with ATP for the receptor's catalytic site, inhibiting downstream growth signals in EGFR-mutant lung cancer cells.

Common Uses: Dose-reduced NSCLC therapy, erlotinib-based regimens for pancreatic cancer with gemcitabine, and maintenance therapy in NSCLC patients.

Administration: Take on an empty stomach — at least 1 hour before or 2 hours after food. Swallow whole with water at the same time daily.

Storage: Store below 25°C in original blister packaging. Protect from moisture and heat. Keep away from children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.